Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter O

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

OLIPUDASE ALFA

Not marketed

Acid Sphingomyelinase Deficiency

DFI12712

ASCEND

NCT02004691

OLIPUDASE ALFA

Not marketed

Sphingomyelin Lipidosis

DFI13803

ASCEND-Peds

EudraCT: 2014-003198-40

OMBRABULIN

Not marketed

Ovarian cancer recurrent

EFC10260

OPSALIN

NCT01332656

OMBRABULIN

Not marketed

Advanced sarcoma

EFC10145

NA

EudraCT: 2007-003592-39

OMBRABULIN

Not marketed

Non-small cell lung cancer

EFC10259

DISRUPT

EudraCT: 2010-019384-11

OMBRABULIN

Not marketed

Advanced solid tumors

TCD11270

NA

NCT01293630

OMBRABULIN

Not marketed

Advanced solid tumors

TCD11379

NA

NCT01193595

OTAMIXABAN

Not marketed

Hepatic Impairment

POP6207

NA

NCT01126086

OTAMIXABAN

Not marketed

Renal Impairment

POP6537

NA

NCT01120314

OTAMIXABAN

Not marketed

Acute Coronary Syndrome

EFC6204

TAO

NCT01076764

OTAMIXABAN

Not marketed

Acute Coronary Syndrome

DRI6624

SEPIA-(ACS1)

NCT00317395

OXALIPLATIN

Eloxatin

Cancer, Pediatric Malignancies

ARD5531 (L795)

NA

NA

OXALIPLATIN

Eloxatin

Biliary Tract Neoplasms

C_8552

EXIBIT

NCT00174564

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

C_8601

CORE

NCT00174616

OXALIPLATIN

Eloxatin

Esophageal Neoplasms

EFC_7127

NA

NCT00259402

OXALIPLATIN

Eloxatin

Cancer, Germ Cell

EFC_7154

NA

NA

OXALIPLATIN

Eloxatin

Head and Neck neoplasms

EFC_7276

FOL FOX 4

NCT00611754

OXALIPLATIN

Eloxatin

Neoplasms

EFC_7407

NA

NCT00611962

OXALIPLATIN

Eloxatin

Endometrial Neoplasms

EFC_7496

NA

NCT00612495

OXALIPLATIN

Eloxatin

Cancer, Colorectal Adjuvant Therapy

EFC3313

MOSAIC

NCT00275210

OXALIPLATIN

Eloxatin

Stomach Neoplasms

L_8107

NA

NCT00611507

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

L_8128

NA

NCT00403624

OXALIPLATIN

Eloxatin

Uterine Neoplasms

L_8311

NA

NCT00782041

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

L_8330

NA

NCT00259363

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

L_8479

PROCTFUL

NCT00263029

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

L_8851

TREE2

NCT00399750

OXALIPLATIN

Eloxatin

Lung Neoplasms

L_8907

GON

NCT00271271

OXALIPLATIN

Eloxatin

Stomach Neoplasms

L_8915

NA

NCT00263354

OXALIPLATIN

Eloxatin

Liver Neoplasms

L_9202

NA

NCT00280618

OXALIPLATIN

Eloxatin

Lung Neoplasms

L_9210

NA

NCT00087802

OXALIPLATIN

Eloxatin

Head and Neck neoplasms

L_9281

BILWEEKLY

NCT00436800

OXALIPLATIN

Eloxatin

Esophageal Neoplasms

L_9326

NA

NCT00160030

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

L_9444

CONCEPT

NCT00129870

OXALIPLATIN

Eloxatin

Stomach Neoplasms

L_9570

CLASSIC

NCT00411229

OXALIPLATIN

Eloxatin

Hepatocellular Carcinoma

OXALI_L_00858

EACH

NCT00471965

OXALIPLATIN

Eloxatin

Hepatocellular Carcinoma

OXALI_L_02859

NA

NCT00559455

OXALIPLATIN

Eloxatin

Rectal Neoplasms

PM_L_0098

NA

EudraCT: 2005-005149-20

OXALIPLATIN

Eloxatin

Pancreatic Neoplasms

PM_L_0126

NA

NCT00261092

OXALIPLATIN

Eloxatin

Ovarian Neoplasms

PM_L_0239

TEACO

NCT00296816

OXALIPLATIN

Eloxatin

Cancer, Gastrointestinal

POP5347

FOLFOX4

NCT00094965

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

R_9262

MASCOT

NCT00263055

OXALIPLATIN

Eloxatin

Colorectal Neoplasms

OXALI_L_03768

GLUTOX

NCT01087658

OXALIPLATIN

Eloxatin

Pancreatic Neoplasms

OXALI_L_04918

NA

NCT01121848


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted